Oxford Biotherapeutics Ltd. has entered into a multiyear, multitarget strategic collaboration with GSK plc to discover novel antibody-based therapeutics for the treatment of cancer.
Richard Turnbull brought an unusual combination of skills to his life’s work. He died on 26 October, aged 65, having been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback